James Robert Dukeminier, | |
468 Criscoe Rd, Union Grove, AL 35175-5104 | |
(256) 843-9095 | |
Not Available |
Full Name | James Robert Dukeminier |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 468 Criscoe Rd, Union Grove, Alabama |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1689433153 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 23441 (Alabama) | Primary |
Mailing Address | Practice Location Address |
---|---|
James Robert Dukeminier, 468 Criscoe Rd, Union Grove, AL 35175-5104 Ph: (256) 843-9095 | James Robert Dukeminier, 468 Criscoe Rd, Union Grove, AL 35175-5104 Ph: (256) 843-9095 |
News Archive
Researchers at the Johns Hopkins School of Medicine have successfully edited the genome of human- induced pluripotent stem cells, making possible the future development of patient-specific stem cell therapies. Reporting this week in Cell Stem Cell, the team altered a gene responsible for causing the rare blood disease paroxysmal nocturnal hemoglobinuria, or PNH, establishing for the first time a useful system to learn more about the disease.
Researchers have conducted the first ever trials of smart pills that can measure intestinal gases inside the body, with surprising results revealing some unexpected ways that fibre affects the gut.
Growing up in West Virginia, Jill Turner saw firsthand the kind of havoc that drug addiction can wreak. "I had a lot of friends who had very promising lives and promising careers ahead of them," the assistant professor in the South Carolina College of Pharmacy says, "but they ended up either overdosing or going to jail for drug-related stuff. It's one of the reasons I went into drug addiction research."
Virginia Supreme Court Chief Justice Leroy Hassell last Thursday launched the Commission on Mental Health Reform, "the broadest review of the state's mental health laws in three decades" intended to produce an "omnibus mental health reform package" to present to the 2008 General Assembly, the Richmond Times-Dispatch reports.
Although the USD 90 million European tissue sealants market is in the growth phase, the rate of growth is projected to be gradual due to sluggish technological advancements, the slow pace of collecting clinical evidence and unclear product demarcations. Moreover, while around 35 per cent of all internal surgical procedures offer the potential for sealants' use, their deployment has been limited to only a few procedures.
› Verified 1 days ago